CoChat

Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome

Tokuyama, Shogo, Wakabayashi, Hiroyuki, Ho, Ing K. · 1996 · European Journal of Pharmacology

The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.

Abstract

To investigate the role of glutamate in the expression of the withdrawal signs from opioids, rats were intracerebroventricularly (i.c.v.) infused continuously with morphine (a mu-opioid receptor agonist, 26 nmol/microliters per h) or butorphanol (a mixed mu/delta/kappa-opioid receptor agonist, 26 nmol/microliters per h) through osmotic minipumps for 3 days. An i.c.v. injection of glutamate (5 and 50 nmol/5 microliters) dose dependently induced withdrawal signs in morphine- or butorphanol-dependent animals. The withdrawal signs precipitated by the glutamate injection were comparable to those precipitated by an opioid receptor antagonist, naloxone (48 nmol/5 microliters), except for the expression of some specific behaviors and the duration of withdrawal signs. Glutamate or naloxone challenge failed to precipitate any withdrawal signs in saline controlled animals. On the other hand, the expression of the withdrawal signs precipitated by glutamate or naloxone in opioid-dependent animals was completely blocked by pretreatment with MK-801 [a NMDA receptor antagonist, (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cycloheptan-5,10-imine], 0.1 mg/kg, i.p. These unique actions of glutamate in continuously opioid-infused rats suggest that a rapid central release of glutamate may be a key factor in the expression of withdrawal signs from opioids. Furthermore, this effect may be mediated by the NMDA subtype of glutamate receptors.

Overview

Integrity signals

Registry

Crossref · 10.1016/0014-2999(95)00645-1

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Feng, 1994, Opioid receptor subtypes modurate pontine excitatory amino acid (EAA) levels differently in butorphanol and morphine dependence, Soc. Neurosci. Abstr., 20, 1232

Metadata

Authors
Tokuyama, S., Wakabayashi, H., & Ho, I. K.
Affiliations
University of Mississippi Medical Center (US)
Corresponding author
Ho, Ing K.
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
1996-01
Volume
295
Issue
2-3
Pages
123-129
ISSN
0014-2999 (ISSN-L)
OpenAlex
W2034348223
Cited by
98
References
39
Citations by year
2026: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 4 · 2012: 5
FWCI
2.16
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • European Journal of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse (DA-05828)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Keywords
opioid withdrawal, glutamate, NMDA receptor, morphine dependence, butorphanol, naloxone, MK-801, mu-opioid receptor, opioid use disorder
MeSH terms
Animals, Behavior, Animal, Male, Morphine, Naloxone, Narcotics, Substance Withdrawal Syndrome, Dizocilpine Maleate, Rats, Sprague-Dawley, Glutamic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. https://app.cochat.ai/papers/10.1016/0014-2999(95)00645-1
The paper
Tokuyama, S., Wakabayashi, H., & Ho, I. K. (1996). Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. European Journal of Pharmacology. https://doi.org/10.1016/0014-2999(95)00645-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.